Literature DB >> 19554760

Effects of stingless bee and honey bee propolis on four species of bacteria.

A P Farnesi1, R Aquino-Ferreira, D De Jong, J K Bastos, A E E Soares.   

Abstract

We examined the antibacterial activities of several types of propolis, including Africanized honey bee green propolis and propolis produced by meliponini bees. The antibacterial activity of green propolis against Micrococcus luteus and Staphylococcus aureus was superior to that of Melipona quadrifasciata and Scaptotrigona sp propolis. Only two samples of propolis (green propolis and Scaptotrigona sp propolis) were efficient against Escherichia coli. Melipona quadrifasciata propolis was better than green propolis and Scaptotrigona sp propolis against Pseudomonas aeruginosa. We concluded that these resins have potential for human and veterinary medicine.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19554760     DOI： 10.4238/vol8-2kerr023

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN： 1676-5680


  16 in total

1.  Cerumen of Australian stingless bees (Tetragonula carbonaria): gas chromatography-mass spectrometry fingerprints and potential anti-inflammatory properties.

Authors:  Flavia Carmelina Massaro; Peter Richard Brooks; Helen Margaret Wallace; Fraser Donald Russell
Journal:  Naturwissenschaften       Date:  2011-02-24

2.  In vivo assessment of the antimalarial and spleen-protective activities of the Saudi propolis methanolic extract.

Authors:  Qwait AlGabbani; Lamjed Mansour; Yasser A Elnakady; Saleh Al-Quraishy; Suliman Alomar; Esam M Al-Shaebi; Abdel-Azeem S Abdel-Baki
Journal:  Parasitol Res       Date:  2016-11-07       Impact factor: 2.289

3.  Effect of Brazilian green propolis on microorganism contaminants of surface of Gorgonzola-type cheese.

Authors:  Frederico Teixeira Correa; Angélica Cristina de Souza; Ernani Augusto de Souza Júnior; Silas Rodrigo Isidoro; Roberta Hilsdorf Piccoli; Disney Ribeiro Dias; Luiz Ronaldo de Abreu
Journal:  J Food Sci Technol       Date:  2019-03-11       Impact factor: 2.701

4.  Pathogen spillover from Apis mellifera to a stingless bee.

Authors:  Terence Purkiss; Lori Lach
Journal:  Proc Biol Sci       Date:  2019-08-07       Impact factor: 5.349

5.  Antiproliferative effects of Tubi-bee propolis in glioblastoma cell lines.

Authors:  Kleiton Silva Borges; María Sol Brassesco; Carlos Alberto Scrideli; Ademilson Espencer Egea Soares; Luiz Gonzaga Tone
Journal:  Genet Mol Biol       Date:  2011-04-01       Impact factor: 1.771

6.  Antimicrobial activity against oral pathogens and immunomodulatory effects and toxicity of geopropolis produced by the stingless bee Melipona fasciculata Smith.

Authors:  Silvana A Liberio; Antônio Luís A Pereira; Richard P Dutra; Aramys S Reis; Maria José A M Araújo; Nadia S Mattar; Lucilene A Silva; Maria Nilce S Ribeiro; Flávia Raquel F Nascimento; Rosane N M Guerra; Valério Monteiro-Neto
Journal:  BMC Complement Altern Med       Date:  2011-11-04       Impact factor: 3.659

7.  Antimicrobial, Antioxidant, Anti-Inflammatory, and Cytotoxic Activities of Propolis from the Stingless Bee Tetragonisca fiebrigi (Jataí).

Authors:  Jaqueline Ferreira Campos; Uilson Pereira Dos Santos; Paola Dos Santos da Rocha; Marcio José Damião; José Benedito Perrella Balestieri; Claudia Andrea Lima Cardoso; Edgar Julian Paredes-Gamero; Leticia Miranda Estevinho; Kely de Picoli Souza; Edson Lucas Dos Santos
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-22       Impact factor: 2.629

Review 8.  Propolis: a wonder bees product and its pharmacological potentials.

Authors:  Vijay D Wagh
Journal:  Adv Pharmacol Sci       Date:  2013-12-09

9.  In vitro antibacterial activities of ethanol extract of iranian propolis (EEIP) against fish pathogenic bacteria (Aeromonas hydrophila, Yersinia ruckeri & Streptococcus iniae).

Authors:  Amir Tukmechi; Abdolghaffar Ownagh; Ali Mohebbat
Journal:  Braz J Microbiol       Date:  2010-12-01       Impact factor: 2.476

10.  Synergetic antimicrobial effects of mixtures of ethiopian honeys and ginger powder extracts on standard and resistant clinical bacteria isolates.

Authors:  Yalemwork Ewnetu; Wossenseged Lemma; Nega Birhane
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-17       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.